Valo Therapeutics Oy
2768695-4ActiveDeveloping novel peptide-coated oncolytic virus immunotherapies for cancer.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2016
- Grunnlagt
Nøkkelbeslutningstakere
Marcella Origgi
Chief Executive Officer
Matti Hautsalo
Member of the Board
Lukasz Kuryk
Chief Development Officer
Andrew Dean
Member of the Board
+23 flere kontakter i Funnelfeedr
Beskrivelse
Valo Therapeutics (ValoTx) is a biotechnology company spun out from the University of Helsinki, specializing in cancer immunotherapy. The organization focuses on developing novel treatments by uniquely combining oncolytic virus therapy, peptide vaccination, and viral vector approaches. Their core pr...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- 16
- MVA-nummer
- FI27686954
Beslutningstakere
27 kontakter i FunnelfeedrMarcella Origgi
Chief Executive Officer
Matti Hautsalo
Member of the Board
Lukasz Kuryk
Chief Development Officer
Andrew Dean
Member of the Board
Jeffrey Bockman
Member of the Scientific and Clinical Advisory Board
Harri Jarvelainen
Chief Operating Officer
Otto Kari
VP, Head of Antigen Business Unit
Vincenzo Cerullo
Scientific Founder and Scientific Advisor
Kevin Harrington
Member of the Scientific and Clinical Advisory Board
David Hinton
Chair of the Board
Hanne Cojoc
Head of Quality and Operations
Leena Ylösmäki
VP Preclinical Development
Eleonora Leggiero
Head of CMC and Italian Operations
Sari Pesonen
Chief Scientific Officer
Austin Smith
Medical Director
Petri Priha
VP of CMC
Charlotta Backman
VP of Clinical Operations and Regulatory Affairs
Paul Porter
Member of the Board
Malcolm K. Brenner
Member of the Scientific and Clinical Advisory Board
Paolo Antonio Ascierto
Member of the Scientific and Clinical Advisory Board
Andre kontakter
Joseph Ndika
Senior Scientist, Antigen Analytics
Suvi Karumo
Laboratory Scientist, Antigen Business Unit
Philip Stanecki
Financial Controller
Matthew Vaughan
Communications Contact
+3 flere kontakter i Funnelfeedr
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrSolid Immuno-Oncology Oy
Developing organ-on-chip technology for advanced cancer treatment decisions.
Sox Therapeutics AB
1 ansatteDeveloping targeted AAV gene therapies for malignant brain tumors.
AAX Biotech AB
5–9 ansatteResearch-driven biotech advancing antibody therapies via proprietary technology.
Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Oncotech Nordic AB
0 ansatteDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Utforsk mer
Spørsmål om Valo Therapeutics Oy
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo